Stock listing

ZLD Stock Price, News, Filings & Events — Zelira Therapeutics Ltd.

Selected listing: ZLD · ASX · AUD · AU

This page tracks Zelira Therapeutics Ltd.'s ZLD:ASX listing on ASX in AUD for AU, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ZLD:ASX. ZLD:ASX is the stock-level entry point for investors researching Zelira Therapeutics Ltd., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Zelira Therapeutics Ltd. is a public company listed on the Australian market under the ticker ZLD. The company has a market capitalization of approximately AUD 4.16 million. Zelira focuses on developing and commercializing cannabinoid-based therapies.

ZLD:ASXAUDAUUpdated August 21, 2026
Zelira Therapeutics Ltd. logo
Ticker
ZLD:ASX
Asset type
Stock
Market cap
$4.2M
Sector
Health Technology
Industry
Pharmaceuticals: Other
Exchange
ASX
Currency
AUD

Zelira Therapeutics Ltd. ZLD:ASX stock context

This page tracks Zelira Therapeutics Ltd.'s ZLD:ASX listing on ASX in AUD for AU, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ZLD:ASX. ZLD:ASX is the stock-level entry point for investors researching Zelira Therapeutics Ltd., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Zelira Therapeutics Ltd. is a public company listed on the Australian market under the ticker ZLD. The company has a market capitalization of approximately AUD 4.16 million. Zelira focuses on developing and commercializing cannabinoid-based therapies.

Latest news from Zelira Therapeutics Ltd.

All Zelira Therapeutics Ltd. news →

Research Zelira Therapeutics Ltd.

Alternate listings